Mobile app support for managing lymphedema in breast cancer patients
The Effect of Mobile-Based Care and Monitoring on Lymphatic Edema Management and Quality of Life in Patients Undergoing Breast Surgery
NA · Sanko University · NCT06203197
This study is testing a mobile app designed to help breast cancer patients manage lymphedema and improve their quality of life during recovery from surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Sanko University (other) |
| Locations | 1 site (Şehitkamil, Gazi̇antep) |
| Trial ID | NCT06203197 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of a mobile-based care application on lymphedema management and quality of life for patients undergoing breast surgery. It is a randomized controlled intervention where participants will use the M-Breast cancer personal care and monitoring system to receive tailored information and support during their perioperative period. The application will provide resources on symptom management, nutrition, and lifestyle adjustments, aiming to enhance patient care and outcomes. The research will be conducted at SANKO University Hospital with a focus on a well-defined patient population.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who are undergoing breast-conserving surgery or lymph node dissection and can communicate in Turkish.
Not a fit: Patients with other significant health issues affecting body image or upper extremity movement may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life and symptom management for breast cancer patients post-surgery.
How similar studies have performed: While there is limited evidence specifically on mobile applications for this purpose, similar digital health interventions have shown promise in improving patient outcomes in other areas.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and over, * Able to understand and speak Turkish, * It is decided to undergo breast-conserving surgery or lymph node dissection, * Using any of the social media applications (facebook, whatsapp, instagram) Exclusion Criteria: * Having another health problem (amputation, visible scar, visible physical disability, etc.) that may affect body image * Those with speech, hearing and vision problems * Having a psychiatric diagnosis * Having a disease that restricts the movement of the upper extremity (rheumatological diseases, fracture, health problem that will cause joint restriction, amputation, etc.). * Never used the application Study termination criteria; * Discontinuation of communication with the patient before the data collection stages are completed * Leaving work voluntarily
Where this trial is running
Şehitkamil, Gazi̇antep
- Ebru Karaaslan — Şehitkamil, Gazi̇antep, Turkey (RECRUITING)
Study contacts
- Study coordinator: ebru karaaslan
- Email: ebrumm.2310@gmail.com
- Phone: +905076501308
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer, breast cancer, post surgical nursing, life quality